Atlas Trials

Gut Microbiota in Intestinal Barrier Damage in Acute Leukemia Patients Undergoing Inpatient Induction

Clinical trial NCT03316456 · COMPLETED

Trial details

NCT number
NCT03316456
Sponsor
Masonic Cancer Center, University of Minnesota
Status
COMPLETED
Study type
OBSERVATIONAL
Chemotherapy-Induced Gut Barrier DamageAcute Leukemia
Start date
2017-08-22
Primary completion
2017-12-26
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.